FDA Approved: DAYBUE STIX — Original Application (Acadia Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves DAYBUE STIX (trofinetide) from Acadia Pharmaceuticals as the original NDA (NDA219884) for Rett syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• DAYBUE STIX (trofinetide)

Snippet

ORIG AP for DAYBUE STIX (TROFINETIDE)